🔜 🧠 “We are about to enter the era of interventional psychiatry, transforming the field of psychiatry.” — Tom Insel, former NIMH Director, at a recent psychedelic science conference. We have invested in many of these new modalities: transcranial focused ultrasound (Sanmai), minimally invasive deep brain stimulation and vagus nerve stimulation (Neurobionics), brain-computer-interfaces (Neuralink), auditory dream engineering (Dust), psychedelic-assisted therapy (atai/Lilly), and real-world-data collection for all (Osmind). Insel also co-authored a Nature paper with Osmind defining the field: + summary: Interventional psychiatry companies: •  tFUS: • Endovascular DBS: •  BCI: •  Dream engineering: •  Psychedelics: P.S. Underfunded: “From 2002-2013, the NIMH did not receive any funding applications for psychedelics. It was all funded and legitimized by philanthropy.” P.S.S. Needed: “The World Health Organization (WHO) predicts that without significant changes, mental illness will cost the world economy $16t by 2030, making it the largest disease burden globally." — UBS: We need significant changes.